throbber
NDA 21-372/S-002
`Page 3
`
`28 JUNE 2005 FINAL VERSION
`
`
`
`
`Patient Information
`
`ALOXI™ (Ah-lock-see)
`Palonosetron HCI injection
`
`Read the Patient Information that comes with ALOXI before your treatment with ALOXI and
`each time you get ALOXI. There may be new information. This information does not take the
`place of talking with your doctor about your medical condition or your treatment. If you have
`questions about ALOXI, ask your doctor or pharmacist.
`
`
`What is ALOXI?
`
`ALOXI is a medicine called an “antiemetic.” ALOXI is used in adults to help prevent the
`nausea and vomiting that happens:
`•
`right away with certain anti-cancer medicines (chemotherapy)
`• or later with certain anti-cancer medicines
`
`
`What is ALOXI used for?
`
`ALOXI is used to prevent nausea and vomiting that may happen:
`• soon after taking certain anti-cancer medicines
`•
`later after taking certain anti-cancer medicines
`
`
`Who should not take ALOXI?
`Do not take ALOXI if you are allergic to any of the ingredients in ALOXI. The active
`ingredient is palonosetron hydrochloride. See the end of this leaflet for a complete list of
`
`ingredients in ALOXI.
`
`ALOXI has not been studied in children under 18 years of age.
`What should I tell my doctor before using ALOXI?
`Tell your doctor about all of your medical conditions, including if you:
`
`

`

`NDA 21-372/S-002
`Page 4
`
`
`• have heart problems including a problem called “congenital QT syndrome”
`• have low potassium in your blood
`• have low magnesium in your blood
`• are pregnant. It is not known if ALOXI may harm your unborn baby. You and your
`doctor should decide if ALOXI is right for you.
`• are breastfeeding. It is not known if ALOXI passes into your milk and if it can harm
`your baby. You should choose to either take ALOXI or breastfeed, but not both.
`
`
`Tell your doctor about all of the medicines you take including prescription and
`nonprescription medicines, vitamins and herbal supplements. ALOXI should be given
`with caution in patients who may be taking other medicines that have caused, or may cause,
`
`severe heart beat changes.
` Especially, tell your doctor if you take:
`“water pills” (diuretics)
`• medicine to control your heartbeat (anti-arrhythmics)
`
`•
`
`• anthracycline (an anti-cancer medicine)
`
`
`How should I use ALOXI?
`
`ALOXI is given in your vein by IV (intravenous) injection. It is only given to you by a
`healthcare provider in a hospital or clinic. ALOXI is usually injected into your vein about 30
`minutes before you get your anti-cancer medicine (chemotherapy).
`
`What are the possible side effects of ALOXI?
`
`ALOXI should be given with caution in patients who have or may develop severe heart beat
`changes from QT prolongation. This can happen in people who have certain heart or other
`
`medical problems or who take certain medicines.
`
`The most common side effects of ALOXI are headache and constipation. Diarrhea and
`dizziness have also been observed.
`
`These are not all the side effects from ALOXI. For more information ask your doctor or
`pharmacist.
`
`

`

`NDA 21-372/S-002
`Page 5
`
`
`General information about ALOXI
`
`Medicines are sometimes prescribed for conditions other than those listed in patient
`information leaflets. ALOXI was prescribed for your medical condition.
`
`This leaflet summarizes the most important information about ALOXI. If you would like more
`
`information, talk with your doctor. You can ask your doctor or pharmacist for information
`about ALOXI that is written for health professionals. You can also visit the ALOXI web site at
`www.ALOXI.com. Or visit www.ManageCINV.com. This is a web site for patients with
`nausea and vomiting from anti-cancer medicines.
`
`
`What are the ingredients in ALOXI?
`
`Active ingredient: palonosetron hydrochloride
`Inactive ingredients: mannitol, disodium edetate, and citrate buffer in water
`
`Rx Only
`
`Mfd by Cardinal Health, Albuquerque, NM, USA and Helsinn Birex Pharmaceuticals, Dublin, Ireland.
`HELSINN, Mfd for Helsinn Healthcare SA, Switzerland
`
`
`MGI PHARMA, INC. Distributed and marketed by MGI PHARMA, INC. Bloomington, MN. 55437 under license of Helsinn Healthcare SA,
`
`Switzerland.
`
`
`ALOXI™ is a trademark of Helsinn Healthcare, SA, Lugano, Switzerland
`©2004 MGI PHARMA, INC. Bloomington, MN. 55437 U.S.A. 445091002 2/04
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket